{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:54:53Z","timestamp":1790960093807,"version":"4.1.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Patients with bleeding and coagulopathic trauma often require more transfusions and have higher mortality rates, motivating research on improving hemostatic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the replacement of clotting factors with frozen plasma (FP) or factor concentrates (fibrinogen concentrate [FC] and prothrombin complex concentrate [PCC]) in the initial resuscitation of patients with trauma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This multicenter, parallel-control, superiority randomized clinical trial was conducted at 6 level I trauma centers in Canada, between April 2021 and February 2023. Eligible patients were those with massive hemorrhage protocol (MHP) activation on admission and aged 16 years or older. Patients were excluded if they received more than 2 red blood cell (RBC) units either before hospital admission or in the hospital prior to randomization or if they had a catastrophic head injury. Follow-up was completed on March 25, 2023. The primary analysis was based on the modified intention-to-treat approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>The intervention group received FC 4 g and PCC 2000 IU in MHP packs 1 and 2. The control group received 4 FP units. Concurrently, patients received 4 RBC units (both packs) and 1 dose of platelets (pack 2). After pack 2, FP was administered at clinician discretion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Primary outcome was the number of allogeneic blood product (RBC, FP, and platelet) units administered within 24 hours. Secondary outcomes included incidence of thromboembolic events, duration of intensive care unit stay, and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 217 patients enrolled, 107 were randomly assigned to the FC-PCC group and 110 to the FP group; 137 patients were included in the primary analysis (66 in the FC-PCC group and 71 in the FP group). Baseline characteristics were similar between groups (median [IQR] age, 38 [29-55] years; 111 males [81.0%]). Among these patients, 95 (69.3%) had blunt mechanisms of injury, and the median (IQR) Injury Severity Score was 29 (19-43). Mean 24-hour transfusions were 20.8 (95% CI, 16.7-25.9) units in the FC-PCC group and 23.8 (95% CI, 19.2-29.4) units in the FP group. The mean ratio was 0.87 (1-sided 97.5% CI, 0.00-1.19;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.20 for superiority). No significant differences were found in thromboembolic complications or 24-hour and 28-day mortality. The trial was terminated after the interim analysis showed conditional power of less than 25%, requiring an impractically large sample to show superiority.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial, clotting factor concentrates were not superior to FP for initial resuscitation of patients with trauma. Efficacy and safety outcomes were similar across the treatment groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT04534751?intr=NCT04534751&amp;amp;amp;rank=1\">NCT04534751<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.32702","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T15:30:49Z","timestamp":1758555049000},"page":"e2532702","source":"Crossref","is-referenced-by-count":12,"title":["Factors in the Initial Resuscitation of Patients With Severe Trauma"],"prefix":"10.1001","volume":"8","author":[{"given":"Luis T.","family":"da Luz","sequence":"first","affiliation":[{"name":"Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"},{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Karkouti","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Anesthesiology and Pain Medicine, University Health Network, Sinai Health System, Women\u2019s College Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Grewal","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marti","family":"Jones","sequence":"additional","affiliation":[{"name":"Biostatistics, ERGOMED PLC, Guildford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Altmann","sequence":"additional","affiliation":[{"name":"ERGOMED PLC, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery B.","family":"Nathens","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"},{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie","family":"Kron","sequence":"additional","affiliation":[{"name":"Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowyl","family":"Notario","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Tory Trauma Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Beckett","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"General Surgery, Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Petrosoniak","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Emergency Medicine, Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Pavenski","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Transfusion Medicine, Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Vogt","sequence":"additional","affiliation":[{"name":"General Surgery, London Health Sciences Centre, London, Ontario, Canada"},{"name":"Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Solh","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"},{"name":"Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Ball","sequence":"additional","affiliation":[{"name":"Western University, London, Ontario, Canada"},{"name":"Critical Care Medicine and Office of Academic Military Medicine, London Health Sciences Centre Trauma Program, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil G.","family":"Parry","sequence":"additional","affiliation":[{"name":"Western University, London, Ontario, Canada"},{"name":"Critical Care Trauma Center, London Health Sciences Centre, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Engels","sequence":"additional","affiliation":[{"name":"General Surgery, Hamilton General Hospital, Hamilton, Ontario, Canada"},{"name":"McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle P.","family":"Zeller","sequence":"additional","affiliation":[{"name":"McMaster University, Hamilton, Ontario, Canada"},{"name":"Michael G. DeGroote Centre for Transfusion Research, Department of Medicine, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Arnold","sequence":"additional","affiliation":[{"name":"McMaster University, Hamilton, Ontario, Canada"},{"name":"Michael G. DeGroote Centre for Transfusion Research, Department of Medicine, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Belley-C\u00f4t\u00e9","sequence":"additional","affiliation":[{"name":"McMaster University, Hamilton, Ontario, Canada"},{"name":"Cardiology and Critical Care, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Evans","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Kingston General Hospital, Kingston, Ontario, Canada"},{"name":"Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Leitch","sequence":"additional","affiliation":[{"name":"Queen\u2019s University, Kingston, Ontario, Canada"},{"name":"Anesthesia and Perioperative Medicine, Kingston General Hospital, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Shih","sequence":"additional","affiliation":[{"name":"Transfusion Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada"},{"name":"University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Jean","family":"Dawe","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Acute Care and Trauma Surgery, Vancouver General Hospital, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gooch","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Emergency Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Callum","sequence":"additional","affiliation":[{"name":"Queen\u2019s University, Kingston, Ontario, Canada"},{"name":"Pathology and Molecular Medicine, Kingston General Hospital, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"issue":"6","key":"zoi250925r1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/01.TA.0000069184.82147.06","article-title":"Acute traumatic coagulopathy.","volume":"54","author":"Brohi","year":"2003","journal-title":"J Trauma"},{"issue":"4","key":"zoi250925r2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tmrv.2021.07.004","article-title":"Pathophysiology of trauma-induced coagulopathy.","volume":"35","author":"Duque","year":"2021","journal-title":"Transfus Med Rev"},{"issue":"3","key":"zoi250925r3","doi-asserted-by":"publisher","first-page":"E546","DOI":"10.9778\/cmajo.20190042","article-title":"A regional massive hemorrhage protocol developed through a modified Delphi technique.","volume":"7","author":"Callum","year":"2019","journal-title":"CMAJ Open"},{"issue":"1","key":"zoi250925r4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00134-020-06266-1","article-title":"Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.","volume":"47","author":"Baksaas-Aasen","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"zoi250925r5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition.","volume":"27","author":"Rossaint","year":"2023","journal-title":"Crit Care"},{"issue":"19","key":"zoi250925r7","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1001\/jama.2023.21019","article-title":"Early and empirical high-dose cryoprecipitate for hemorrhage after traumatic injury: the CRYOSTAT-2 randomized clinical trial.","volume":"330","author":"Davenport","year":"2023","journal-title":"JAMA"},{"issue":"16","key":"zoi250925r8","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jama.2023.4080","article-title":"Efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion: the PROCOAG randomized clinical trial.","volume":"329","author":"Bouzat","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"zoi250925r9","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","article-title":"Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial.","volume":"4","author":"Innerhofer","year":"2017","journal-title":"Lancet Haematol"},{"issue":"9","key":"zoi250925r10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-051003","article-title":"Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multicentre trial).","volume":"11","author":"da Luz","year":"2021","journal-title":"BMJ Open"},{"issue":"20","key":"zoi250925r11","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"9957","key":"zoi250925r12","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/S0140-6736(14)61040-0","article-title":"HEAT-PPCI sheds light on consent in pragmatic trials.","volume":"384","author":"Shaw","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"zoi250925r13","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/CCM.0b013e3181920851","article-title":"Deferred proxy consent in emergency critical care research: ethically valid and practically feasible.","volume":"37","author":"Jansen","year":"2009","journal-title":"Crit Care Med"},{"issue":"6","key":"zoi250925r14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/bja\/aew343","article-title":"Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial.","volume":"117","author":"Nascimento","year":"2016","journal-title":"Br J Anaesth"},{"issue":"20","key":"zoi250925r15","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1001\/jama.2019.17312","article-title":"Effect of fibrinogen concentrate vs cryoprecipitate on blood component transfusion after cardiac surgery: the FIBRES randomized clinical trial.","volume":"322","author":"Callum","year":"2019","journal-title":"JAMA"},{"issue":"8","key":"zoi250925r16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-091381","article-title":"Protocol for a phase 3, randomised, active-control study of four-factor prothrombin complex concentrate versus frozen plasma in bleeding adult cardiac surgery patients requiring coagulation factor replacement: the LEX-211 (FARES-II) trial.","volume":"14","author":"Karkouti","year":"2024","journal-title":"BMJ Open"},{"issue":"4","key":"zoi250925r17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0197-2456(84)80014-8","article-title":"Designs for group sequential tests.","volume":"5","author":"Fleming","year":"1984","journal-title":"Control Clin Trials"},{"issue":"1","key":"zoi250925r18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/TA.0000000000001938","article-title":"The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: a propensity matched analysis.","volume":"85","author":"Jehan","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"zoi250925r19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/TA.0000000000002262","article-title":"Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: a nationwide propensity-matched analysis.","volume":"87","author":"Zeeshan","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"zoi250925r20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/TA.0000000000000502","article-title":"The new metric to define large-volume hemorrhage: results of a prospective study of the critical administration threshold.","volume":"78","author":"Savage","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"zoi250925r21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.injury.2018.11.014","article-title":"Accuracy of massive transfusion as a surrogate for significant traumatic bleeding in health administrative datasets.","volume":"50","author":"Tran","year":"2019","journal-title":"Injury"},{"issue":"1","key":"zoi250925r22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13049-020-00774-1","article-title":"Pre-hospital blood transfusion: an ESA survey of European practice.","volume":"28","author":"Thies","year":"2020","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"zoi250925r23","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1111\/trf.17374","article-title":"Use of prehospital transfusion by French emergency medical services: a national survey.","volume":"63","author":"Bichot","year":"2023","journal-title":"Transfusion"},{"key":"zoi250925r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.resplu.2022.100357","article-title":"A descriptive analysis of the Canadian Prehospital and Transport Transfusion (CAN-PATT) network.","volume":"13","author":"Greene","year":"2023","journal-title":"Resusc Plus"},{"issue":"3","key":"zoi250925r25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1017\/cem.2018.457","article-title":"Blood on board: the development of a prehospital blood transfusion program in a Canadian helicopter emergency medical service.","volume":"21","author":"Krook","year":"2019","journal-title":"CJEM"},{"issue":"1","key":"zoi250925r26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/pst.2155","article-title":"Confidence intervals for exposure-adjusted rate differences in randomized trials.","volume":"21","author":"Scosyrev","year":"2022","journal-title":"Pharm Stat"},{"issue":"4","key":"zoi250925r27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/TA.0000000000004463","article-title":"A machine learning-based Coagulation Risk Index predicts acute traumatic coagulopathy in bleeding trauma patients.","volume":"98","author":"Richards","year":"2025","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"zoi250925r28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/TA.0000000000001047","article-title":"Automated continuous vital signs predict use of uncrossed matched blood and massive transfusion following trauma.","volume":"80","author":"Parimi","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"zoi250925r29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/TA.0000000000003031","article-title":"Comparison of massive and emergency transfusion prediction scoring systems after trauma with a new Bleeding Risk Index score applied in-flight.","volume":"90","author":"Yang","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"zoi250925r30","doi-asserted-by":"publisher","DOI":"10.1097\/AS9.0000000000000314","article-title":"Early prediction of massive transfusion for patients with traumatic hemorrhage: development of a multivariable machine learning model.","volume":"4","author":"Benjamin","year":"2023","journal-title":"Ann Surg Open"},{"issue":"2S","key":"zoi250925r31","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1097\/TA.0000000000003300","article-title":"Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference.","volume":"91","author":"Spinella","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"zoi250925r32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/SLA.0000000000004563","article-title":"Evidence-based and clinically relevant outcomes for hemorrhage control trauma trials.","volume":"273","author":"Holcomb","year":"2021","journal-title":"Ann Surg"},{"issue":"1","key":"zoi250925r33","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2024-001420","article-title":"Thromboprophylaxis in hospitalized trauma patients: a systematic review and meta-analysis of implementation strategies.","volume":"9","author":"Ratnasekera","year":"2024","journal-title":"Trauma Surg Acute Care Open"},{"issue":"1","key":"zoi250925r34","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2023-001214","article-title":"Identification of major hemorrhage in trauma patients in the prehospital setting: diagnostic accuracy and impact on outcome.","volume":"9","author":"Wohlgemut","year":"2024","journal-title":"Trauma Surg Acute Care Open"},{"issue":"5","key":"zoi250925r35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.injury.2014.12.026","article-title":"Clinical gestalt and the prediction of massive transfusion after trauma.","volume":"46","author":"Pommerening","year":"2015","journal-title":"Injury"},{"issue":"1","key":"zoi250925r36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.injury.2018.11.026","article-title":"Massive hemorrhage protocol survey: marked variability and absent in one-third of hospitals in Ontario, Canada.","volume":"50","author":"Chin","year":"2019","journal-title":"Injury"},{"key":"zoi250925r6","unstructured":"Ontario Regional Blood Coordinating Network (ORBCON). Provincial massive hemorrhage toolkit. Transfusion Ontario. April 30, 2021. Accessed October 15, 2024. https:\/\/transfusionontario.org\/en\/provincial-massive-hemorrhage-toolkit\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2839205\/da_luz_2025_oi_250925_1765834292.9589.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:00:18Z","timestamp":1766160018000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2839205"}},"subtitle":["The FiiRST-2 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.32702","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}